Publications by authors named "Armando Zuniga"

Claim this Profile
A
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus.
Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle

NPJ Vaccines· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
Pierre-Louis Hervé, Véronique Dhelft, Armando Zuniga, Arin Ghasparian, Oliver Rassek

Vaccine· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus.
Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle

NPJ Vaccines· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A.
Marco Tamborrini, Nina Geib, Aniebrys Marrero-Nodarse, Maja Jud, Julia Hauser, Armando Zuniga

Vaccines (Basel)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector.
Marlyse C Knuchel, René R Marty, Teldja Neige Azzouz Morin, Orhan Ilter, Armando Zuniga

Hum Vaccin Immunother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma.
Giuseppina Cantarella, Matthias Liniger, Armando Zuniga, John T Schiller, Martin Billeter

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses.
Matthias Liniger, Armando Zuniga, Teldja Neige Azzouz Morin, Behazine Combardiere, Rene Marty

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.
Matthias Liniger, Armando Zuniga, Azaibi Tamin, Teldja N Azzouz-Morin, Marlyse Knuchel

Vaccine· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated measles virus as a vaccine vector.
Armando Zuniga, Zili Wang, Matthias Liniger, Lars Hangartner, Michael Caballero

Vaccine· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of viral vectors for the development of vaccines.
Matthias Liniger, Armando Zuniga, Hussein Y Naim

Expert Rev Vaccines· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of a multidisciplinary team care approach to improve glycemic control and quality of life by the prevention of complications among diabetic patients.
Catherine Codispoti, Malinda Reddish Douglas, Tonya McCallister, Armando Zuniga

J Okla State Med Assoc· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.
Eckhard Flechsig, Ivan Hegyi, Rainer Leimeroth, Armando Zuniga, Daniela Rossi

EMBO J· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis